Leerink Swann Starts Sarepta Therapeutic (SRPT) at Outperform, $45 PT
Tweet Send to a Friend
Leerink Swann initiates coverage on Sarepta Therapeutic (NASDAQ: SRPT) with a Outperform and $45 price target as they are bullish ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
